TPST

Tempest Therapeutics, Inc. - Common Stock (TPST)

About Tempest Therapeutics, Inc. - Common Stock (TPST)

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Details

Daily high

$0.94

Daily low

$0.77

Price at open

$0.92

52 Week High

$12.23

52 Week Low

$0.74

Market cap

15.5M

Dividend yield

Volume

1.8M

Avg. volume

7.7M

P/E ratio

-.22

Tempest Therapeutics, Inc. - Common Stock News